Anebulo Pharmaceuticals Inc

Market Cap

$19M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.38-$0.75 (-66.81%)

Jun 5, 2026

52W High $3.3352W Low $0.33

Company Details

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The co...

CEO

—

IPO Date

May 7, 2021

Website

www.anebulo.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$8M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Feb 12, 2026

Q1 2026

Nov 13, 2025

FY 2025

Sep 29, 2025

Q4 2025

Sep 29, 2025

Q3 2025

May 13, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee